The Japan Veterinary Implants Devices Market was valued at $10.27 Million in 2026 and projected to reach to $13.86 Million by 2031, representing a compound annual growth rate of 6.2%. Japan's veterinary implants devices market is poised for robust expansion through 2031, driven by rising pet ownership, increasing pet healthcare spending, and a growing geriatric animal population requiring advanced surgical interventions.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Japan's veterinary implants devices market is valued at USD 10.27 million in 2026 and is projected to reach USD 13.86 million by 2031, demonstrating steady growth in the region's pet healthcare sector.
With a CAGR of 6.2% from 2026 to 2031, Japan's market growth outpaces the global average of 5.7%, reflecting increasing investment in advanced veterinary care and pet wellness.
Japan's sophisticated veterinary healthcare system and high pet ownership rates drive demand for premium orthopedic and dental implants, positioning the country as a key market for innovative implant solutions.
Japan's growing elderly pet demographic creates sustained demand for joint replacement, spinal implants, and dental restoration procedures, supporting long-term market expansion.
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
|
|
Enables controlled delivery of growth-promoting hormones through veterinary cattle implants, including the Synovex portfolio, across different stages of beef production | Supports improved weight gain, feed efficiency, and production performance through sustained implant-based hormone delivery |
|
|
Provides sustained-release veterinary implants, including Suprelorin, for controlled hormonal and reproductive management in dogs and ferrets | Enables reversible and long-duration reproductive management while reducing the need for repeated treatments or surgical intervention |
|
|
Develops veterinary orthopedic implant systems, including total hip replacement, knee, elbow, and fracture fixation systems, designed for companion-animal orthopedic procedures | Improves joint reconstruction, skeletal stabilization, and mobility in dogs and other companion animals while supporting treatment of complex orthopedic conditions |
|
|
Develops growth-promoting implant technologies, including Revalor implants, for controlled hormone delivery in beef cattle | Improves cattle growth and feed efficiency while supporting production-performance management across different livestock production stages |
|
|
Develops veterinary orthopedic implant systems, including plates, screws, fracture-fixation systems, and TPLO/TTA solutions for companion animals | IImproves cattle growth and feed efficiency while supporting production-performance management across different livestock production stages |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | ASIA PACIFIC (Volume) |
| Forecast Period | 2026-2030 |
| Growth Rate | CAGR of 5.7% from 2026 to 2030 |
| Largest Segment | NORTH AMERICA (Volume) |
| Market Size Base Year (Billions) | ~USD 0.74 (2026) |
| Revenue Forecast (Billions) | ~USD 0.93 (2030) |
| Segments Covered | Implant Device, Type, Animal Type, Application, End User, Volume, Implant Device By Volume |
7 segment dimensions are covered across the global market.
Japan's veterinary implants devices market is valued at USD 10.27 million in 2026.
Japan's veterinary implants devices market is projected to reach USD 13.86 million by 2031.
Japan's market is expected to grow at a compound annual growth rate of 6.2% from 2026 to 2031.
Japan's growth is driven by advanced veterinary infrastructure, rising pet ownership, aging pet populations, and strong regulatory frameworks supporting implant adoption.
Japan's 6.2% CAGR exceeds the global average of 5.7%, indicating stronger regional market momentum and demand for veterinary implant devices.
This study involved four major activities in estimating the size of the veterinary implant devices market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.
The secondary research process involved the widespread use of secondary sources, directories, databases (Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the veterinary implant devices market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, product managers, R&D and regulatory affairs heads, and business development managers from companies manufacturing veterinary orthopedic, cardiovascular, drug delivery, and monitoring implants, as well as distributors of veterinary surgical products. The primary sources from the demand side include board-certified veterinary surgeons, veterinary cardiologists, hospital and practice owners, procurement and purchase managers of veterinary hospital groups, livestock veterinarians and farm managers, researchers at veterinary schools and contract research organizations, and wildlife and zoo veterinarians. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.
A breakdown of the primary respondents is provided below:

*C-level primaries include CEOs, CFOs, COOs, and VPs.
*Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
The research methodology used to estimate the size of the veterinary implant devices market includes the following details.
The market sizing was undertaken from the global side.
Country-level Analysis: The size of the veterinary implant devices market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of implant devices in the overall veterinary medical devices market was obtained from secondary data and validated by primary participants to arrive at the total market. Primary participants further validated the numbers.
Geographic Market Assessment (By Region and Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual implant device segments by end user and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall veterinary implant devices market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
The above-mentioned data was consolidated and added with detailed input and analysis from MarketsandMarkets and presented in this report.

After arriving at the overall size of the global veterinary implant devices market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.
Veterinary implant devices are medical devices placed fully or partially inside an animal's body, surgically, by injection, or orally in the case of intraruminal boluses, and left in place to repair or replace anatomical structures, support organ function, deliver drugs or hormones over time, or monitor physiological and behavioral parameters.
With the given market data, MarketsandMarkets offers customizations as per the company's specific needs. The following customization options are available for the report:
Product matrix providing a detailed comparison of the implant device portfolios of the top five companies
Full forecast, segment splits, and company analysis for all Veterinary Implants Devices Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report